| Literature DB >> 28612022 |
Raja Atreya1, Markus F Neurath1.
Abstract
The induction and subsequent maintenance of mucosal healing has emerged as one of the central therapeutic goals in the management of patients with inflammatory bowel disease (IBD) (Crohn's disease and ulcerative colitis). Current and novel treatment options are assessed regarding their therapeutic efficacy on the basis of their ability to induce mucosal healing. However, there is still substantial debate about the precise definition of mucosal healing. Here, we will give an overview regarding the definitions of mucosal healing as well as its probable effects on long-term disease behavior and finally focus on current and potential therapeutic targets to achieve this therapeutic goal in IBD patients.Entities:
Keywords: Biologicals; Inflammatory bowel diseases; Mucosal healing; Oligonucleotides; Small molecules
Year: 2017 PMID: 28612022 PMCID: PMC5465787 DOI: 10.1159/000458006
Source DB: PubMed Journal: Visc Med ISSN: 2297-4725